Drug
Desoxyepothilone B clinical trials
Also written Utidelone and KOS-862.
- studies test it
- 33
- open now
- 16
- in phase 3
- 5
- first study started
- 2001
Keep track of what changes. Save the desoxyepothilone B studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Other names
Studies by the year they started
33 studies that test it; most in 2023 (6)
| Year | Studies |
|---|---|
| 2001 | 1 |
| 2003 | 3 |
| 2004 | 2 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 6 |
| 2024 | 4 |
| 2025 | 5 |
| 2026 | 3 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 5
- Phase 2
- 26
- Phase 3
- 5
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 17 · Other 16
Beijing Biostar Pharmaceuticals Co., Ltd. (11) · Henan Cancer Hospital (4) · Bristol-Myers Squibb (3) · Fudan University (3) · Memorial Sloan Kettering Cancer Center (2) · Biostar Pharma, Inc. (2) · Min Yan, MD (1) · Hoffmann-La Roche (1)
Often tested with
Tested in the same studies.
Capecitabine (5) · Bevacizumab (4) · Trastuzumab (1) · Toripalimab (1) · HMPL-013 (1) · Oxaliplatin (1) · Tislelizumab (1) · Anlotinib (1)
Studies
Open first, then newest update. How each study uses desoxyepothilone B is read from its arms, and is right about nine times in ten.
Testing it · 33
- A Single-arm, Prospective Phase Ⅱ Clinical Study of Utidelone Combined With Capecitabine in the Treatment of Active Brain Metastasis of TNBCRecruitingPhase 2Henan Cancer HospitalNCT06598046Written as Utidelone and capecitabine
- A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain MetastasesRecruitingPhase 2Biostar Pharma, Inc.NCT06764940Written as Utidelone
- Efficacy and Safety of Utidelone Capsule and Utidelone Injection in Patients With HER-2 Negative Advanced Breast CancerNot yet recruitingPhase 3Beijing Biostar Pharmaceuticals Co., Ltd.NCT07684456Written as Utidelone Capsule
- Utidelone Combined With Bevacizumab in the Treatment of ≥ 2 Lines of HER-2 Negative Advanced Breast CancerRecruitingPhase 2Henan Cancer HospitalNCT05398861Written as utidelone injection
- A Phase II Study of Utidelone With Toripalimab in Advanced Cervical CancerNot yet recruitingPhase 2Zhongnan HospitalNCT07363330Written as Utidelone plus Toripalimab
- Utidelone Capsule Combined With Fluoropyrimidine- and Platinum-containing Therapy in First-line Treatment of Patients With Gastric or Gastroesophageal Junction AdenocarcinomaRecruitingPhase 2/3Beijing Biostar Pharmaceuticals Co., Ltd.NCT06841679Written as Utidelone Capsule
- Phase II Clinical Study of Utidelone Capsule (UTD2) in Patients With Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerNot yet recruitingPhase 2Beijing Biostar Pharmaceuticals Co., Ltd.NCT07044349Written as Utidelone capsule 75mg/m2/d QD
- Comparing UTD2 Combined With Capecitabine to Capecitabine as Adjuvant Therapy for Non-pCR TNBC PatientsNot yet recruitingPhase 3Fudan UniversityNCT07021261Written as Utidelone plus capecitabine
- Phase II Study of Utidelone Plus Fruquintinib Combination Therapy for Platinum-Resistant Recurrent Ovarian CancerNot yet recruitingPhase 2Fudan UniversityNCT06973421Written as Utidelone Capsules
- Utidelone Capsule Monotherapy for Patients with Advanced Solid TumorsNot yet recruitingPhase 2Beijing Biostar Pharmaceuticals Co., Ltd.NCT06730581Written as Utidelone Capsule 60mg/m2/d
- Utidelone Injection Combined with Bevacizumab Injection for Non-small Cell Lung Cancer Patients with Brain MetastasesNot yet recruitingPhase 2Beijing Biostar Pharmaceuticals Co., Ltd.NCT06683703Written as Utidelone
- The Efficacy and Safety of Utidelone Plus Tirelizumab and Bevacizumab for Advanced or Metastatic Triple-negative Breast Cancer (UTILIZABLE) ：Single-arm, Prospective, Open Clinical StudyRecruitingPhase 2Huihua XiongNCT06125080Written as Utidelone
- Utidelone Versus Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung CancerRecruitingPhase 3Beijing Biostar Pharmaceuticals Co., Ltd.NCT05673590Written as Utidelone Injection
- Utidelone Versus Docetaxel in HER2-negative Locally Advanced or Metastatic Breast CancerRecruitingPhase 3Sun Yat-sen UniversityNCT05430399Written as utidelone
- Utidelone Treated for the Recurrent or Metastatic Urothelial CarcinomaRecruitingPhase 2Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNCT05895864Written as utidelone injection
- Utidelone and Anlotinib in Advanced Recurrent Metastatic Esophageal CancerRecruitingPhase 2Peking UniversityNCT05866510Written as Utidelone and anlotinib
- Utidelone Capsule Plus Capecitabine (CAP) for Metastatic Breast CancerActive, not recruitingPhase 2Min Yan, MDNCT06458413Written as Utidelone Capsule Plus Capecitabine
- Phase I-II Clinical Trial of Utidelone Capsule in Patients With Advanced Solid TumorsActive, not recruitingPhase 1/2Beijing Biostar Pharmaceuticals Co., Ltd.NCT05700084Written as Utidelone Capsule (Part 1)
- A Phase II Clinical Study of Utidelone and Bevacizumab With or Without Etoposide in Patients With Brain Metastases From Malignant Solid TumorsWithdrawnPhase 2Tianjin Medical University Cancer Institute and HospitalNCT07449481Written as Utidelone
- Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Solid TumorsCompletedPhase 2Beijing Biostar Pharmaceuticals Co., Ltd.NCT04911907Written as utidelone injection
See all 33 studies that test desoxyepothilone B →
Given in every arm · 2 — desoxyepothilone B is usual care beside what is tested
- Neoadjuvant Therapy With Weekly Utidelone Combined With Cisplatin for Patients With Breast Cancer (NeoURANIA)Not yet recruitingPhase 2RenJi HospitalNCT06510465Written as utidelone
- Study of Utidelone Based Neoadjuvant Treatment on Early High-risk or Locally Advanced Breast CancerNot yet recruitingPhase 2Cancer Institute and Hospital, Chinese Academy of Medical SciencesNCT05983094Written as Utidelone
As the comparator · 1 — what is tested is compared with desoxyepothilone B
Codes
What other systems call desoxyepothilone B · ClinicalTrials.gg INT004091
- MeSH (NLM) C114026desoxyepothilone BOne source NLM
- UNII (FDA) T0358E0YUFUTIDELONEConfirmed FDA, NLM
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C114026 | desoxyepothilone B | One source NLM |
| UNII (FDA) | T0358E0YUF | UTIDELONE | Confirmed FDA, NLM |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.